Nektar Therapeutics (NASDAQ:NKTR) Investor Investigation over Possible Violations of Securities Laws
An investigation on behalf of investors of Nektar Therapeutics (NASDAQ:NKTR) shares over potential securities laws violations by Nektar Therapeutics and certain of its directors and officers in connection certain financial statements was announced.
View full press release